Experimental drug targets gut damage in transplant patients
Disease control
Terminated
This Phase 2 trial tested apraglutide, a drug that helps repair the gut lining, in 31 people with severe gastrointestinal graft-versus-host disease (GVHD) after a stem cell transplant. Participants had GVHD that did not respond to steroids. The study aimed to see if apraglutide i…
Phase: PHASE2 • Sponsor: VectivBio AG • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC